BiomX PHGE
NYSE PHGE
$1.71 +0.09 (+5.56%)
As of: Sep 10, 2026 · 10:45 AM EDT

BiomX (PHGE) Receivables - Net (2024 - 2026)

BiomX's (PHGE) quarterly Receivables - Net came in at $327000.0 in Q2 2026, down 65.21% year-over-year from $940000.0 in Q2 2025, and down 65.21% quarter-over-quarter from $940000.0 in Q2 2025.

Analysis

BiomX (PHGE) Receivables - Net (2024 - 2026) Analysis & Trends

BiomX has disclosed Receivables - Net across 3 years of filings, most recently posting $327000.0 for Q2 2026.

  • In Q2 2026, Receivables - Net fell 65.21% year-over-year to $327000.0; the TTM figure through Jun 2026 stood at $327000.0 (down 65.21% YoY), while the FY2024 annual figure was $768000.0, changed N/A from the prior year.
  • Receivables - Net came in at $327000.0 for Q2 2026 at BiomX, down from $940000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $940000.0 in Q2 2025 to a low of $327000.0 in Q2 2026.
  • Average Receivables - Net over 3 years is $598833.3, with a median of $581500.0 recorded in 2024.
  • Year-over-year, Receivables - Net soared 137.97% in 2025 and slumped 65.21% in 2026.
  • Over 3 years, Receivables - Net stood at $768000.0 in 2024, then advanced by 22.4% to $940000.0 in 2025, then tumbled by 65.21% to $327000.0 in 2026.
  • Per Business Quant data, the three most recent Receivables - Net figures were $327000.0 in Q2 2026, $940000.0 in Q2 2025, and $768000.0 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 207.59 Bn 193.60 Bn 7.24 Bn
2 Gilead Sciences 178.73 Bn 175.55 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.17 Bn 123.32 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.73 Bn 73.73 Bn 3.93 Bn
5 Argenx Se 61.01 Bn 55.82 Bn 1.37 Bn
6 Moderna 53.40 Bn 48.27 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.49 Bn 30.18 Bn 992.69 Mn
8 Biogen 31.64 Bn 30.35 Bn 1.96 Bn
9 Roivant Sciences 29.66 Bn 29.66 Bn 1.16 Mn
10 BiomX 17.64 Mn 17.06 Mn 97,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 327,000.00
Jun 30, 2025 940,000.00
Mar 31, 2025 768,000.00
Dec 31, 2024 768,000.00
Sep 30, 2024 395,000.00
Jun 30, 2024 395,000.00